UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055484
Receipt number R000062739
Scientific Title What Are the Key Elements of Dementia Preparedness? -A Qualitative Study Toward Developing a Dementia Preparedness Program.
Date of disclosure of the study information 2024/09/11
Last modified on 2025/07/11 10:14:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

What Are the Key Elements of Dementia Preparedness? -A Qualitative Study Toward Developing a Dementia Preparedness Program."

Acronym

What Are the Key Elements of Dementia Preparedness? -A Qualitative Study.

Scientific Title

What Are the Key Elements of Dementia Preparedness? -A Qualitative Study Toward Developing a Dementia Preparedness Program.

Scientific Title:Acronym

What Are the Key Elements of Dementia Preparedness? -A Qualitative Study."

Region

Japan


Condition

Condition

Dementia

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify what are the key factors to prepare for dementia

Basic objectives2

Others

Basic objectives -Others

Elements to be included in a dementia preparedness program

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Important Factors to Prepare for Dementia

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A. Persons with dementia who applied after seeing the Opportunity Act or the Research Cooperation flyer
1: have a diagnosis of dementia, and those with mild dementia, i.e., those with a Clinical Dementia Rating of Stage 0.5 or Stage 1 before the start of the interview.
2: Family members who can be present during the interview.
3: The subjects and their surrogates (family members) who gave their consent to the study after the study was explained to them.
*The male/female ratio should be adjusted so that it is between 40% and 60%.

B. Family caregivers who have applied for the study after reading the Kikan Method or the flyer for research cooperation
1: Those who are caring for a family member with dementia.
2: Those who agreed to cooperate in the research after the research was explained to them.
*The male/female ratio will be adjusted so that it is between 40% and 60%.
*The ratio of male and female participants shall be adjusted so that the ratio of male and female participants is between 40% and 60%.

C. Professionals who support persons with dementia who have applied for the study after reading the resource guide or the research cooperation flyer.
1: Those with at least 10 years of experience in dementia support
2: Those who have professional qualifications in medical/caregiving/welfare, etc.
3: Those who have given their consent to cooperate in the research after the research has been explained to them.
The ratio of male to female participants should be adjusted so that it is between 40% and 60%.
The ratio of men to women should be adjusted so that the ratio of men to women is between 40% and 60%.

Key exclusion criteria

A. Persons with dementia
1: Persons with significant depressive symptoms, i.e., those who score 10 or more on the Geriatric Depression Scale before the interview begins.
2: Other subjects deemed inappropriate by the principal investigator

B. Family caregivers
1: Subjects with significant depressive symptoms, i.e., those who scored 10 or more on the GDS before the start of the interview.
2: Others whom the principal investigator judges to be inappropriate as subjects.

C. Professionals who support the person with dementia
1: Other subjects who are judged as inappropriate by the principal investigator.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Risa
Middle name
Last name OTSUKA

Organization

Shinshu university

Division name

School of health sciences

Zip code

3908621

Address

3-1-1, Asahi, Matsumoto, Nagano, Japan

TEL

0263-37-2401

Email

2r022otsuka4@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Risa
Middle name
Last name Otsuka

Organization

Shinshu university

Division name

School of health sciences

Zip code

3908621

Address

3-1-1, Asahi, Matsumoto, Nagano, Japan

TEL

0263372401

Homepage URL


Email

2r022otsuka4@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu university

Institute

Department

Personal name



Funding Source

Organization

Shinshu university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu university

Address

3-1-1, Asahi, Matsumoto, Nagano, Japan

Tel

0263372401

Email

2r022otsuka4@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 07 Month 09 Day

Date of IRB

2024 Year 07 Month 09 Day

Anticipated trial start date

2024 Year 07 Month 10 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Qualitative analysis of what people with dementia, family members, and professionals should know before they develop dementia, surveyed through semi-structured interviews.


Management information

Registered date

2024 Year 09 Month 11 Day

Last modified on

2025 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062739